HealthTech Bioactives partners with Abolis for biobased production of high-value polyphenols
In France, Abolis said that HealthTech Bioactives (HTBA) said it has chosen the company as a partner to develop strains to produce valuable polyphenols. The initial phase of the partnership will focus on developing two high-value molecules with limited sourcing availability. Up to eight additional molecules will be added to the development pipeline. This strategic […]
